Navigation Links
Optimer Pharmaceuticals and Cubist Pharmaceuticals Announce Collaboration to Co-Promote DIFICID™ (Fidaxomicin) for Clostridium difficile Infection in the United States
Date:4/6/2011

llion ($15 million per year) over the two years beginning with the first commercial sale of DIFICID. Cubist is also eligible to receive an additional $5 million in the first year after first commercial sale and $12.5 million in the second year of the agreement if mutually agreed upon annual sales targets are achieved, as well as a portion of Optimer's gross profits from any sales above the specified annual sales target levels.

Scheduled Conference Call

Optimer will host a conference call today at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time) to discuss the outcome of the Anti-Infective Drugs Advisory Committee as well as the Cubist collaboration. To participate in the conference call, please dial (877) 280-7280 from the U.S., or (678) 825-8232 for international callers. Please specify to the operator that you would like to join "Optimer's Conference Call." The conference call will be webcast live under the Investors section of Optimer's website at www.optimerpharma.com, where it will be archived for 30 days following the call. Please connect to Optimer's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary. 

About DIFICID™ (Fidaxomicin)

DIFICID™ (fidaxomicin) is an investigational antibiotic with a novel mechanism of action, which inhibits the bacterial enzyme RNA polymerase, resulting in the rapid killing of C. difficile. The narrow-spectrum profile of DIFICID eradicates C. difficile selectively with minimal disruption to the normal intestinal flora, while the alternative antibiotics used to treat CDI, metronidazole and vancomycin, have been shown to disrupt the gut flora. DIFICID facilitates the return of normal physiological conditions in the colon which may be responsible for reducing CDI recurrence rates. In two Phase 3 trials for the treatment of CD
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Optimer Announces that the U.S. Food and Drug Administrations Anti-Infective Drugs Advisory Committee Voted Unanimously to Recommend Approval of Novel Antibiotic Dificid™ for Treatment of Patients with Clostridium difficile infection (CDI)
2. Trading Halted Today in Optimer Pharmaceuticals Stock
3. Optimer Pharmaceuticals Announces Presentation at SHEA of Data Highlighting the Burden of Clostridium difficile Infection (CDI) in Hospital Patients
4. Optimer Pharmaceuticals Announces Presentation at Upcoming SHEA Annual Meeting Regarding Hospital CDI Patients at Risk of Recurrence and Mortality
5. Optimer Pharmaceuticals Announces Issuance of Key Patent Covering Fidaxomicin Methods of Use as a Treatment of Clostridium difficile infection
6. Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results
7. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2010 Financial Results
8. Optimer Pharmaceuticals to Present at March 2011 Investor Conferences
9. Optimer Pharmaceuticals, Inc. Prices Public Offering of Common Stock
10. Optimer Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
11. Optimer Pharmaceuticals and Astellas Announce Collaboration to Commercialize Fidaxomicin for Clostridium difficile infection (CDI) in Europe and Certain Other Countries in Middle East, Africa and CIS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)...   Memorial Hermann Health System and The ... a new partnership to provide a new level of specialized ... in the greater Houston area. ... exclusive provider of professional breast radiology services for five of ... The Woodlands , Northeast, Southwest and ...
(Date:8/21/2014)... 2014 The spinal column is one of the ... carried to and from the brain through the column control ... Injury or ailment here can be life altering, and leave ... control over their body. Though back injury and disease can ... are more options available to make things better than ever ...
(Date:8/21/2014)... 2014  Decision Resources Group finds that, for ... Brazil and Mexico ... prescribe long-acting beta-agonist (LABA)- and long-acting muscarinic antagonist ... current severe cost/coverage constraints. Therefore, new brands of ... launch in these countries—which will considerably expand the ...
Breaking Medicine Technology:Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 2Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 3Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 4Don't Live in Pain: Four Life Improving Benefits of Back Surgery 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 3
... Inc. (Nasdaq: NLTX ), a company focused on ... announced its second quarter financial results for 2010. ... Nile reported a net loss of approximately $1.5 million, or ... $2.5 million, or $0.10 per share, during the second quarter ...
... FRANCISCO, Calif., Aug. 16 Titan Pharmaceuticals, Inc. (OTC Bulletin ... the second quarter ended June 30, 2010. Total ... consisting primarily of grant and royalty revenues. Grant revenue from ... Phase 3 clinical study of Probuphine® was approximately $1.29 million, ...
Cached Medicine Technology:Nile Therapeutics Reports 2010 Second Quarter Financial Results 2Nile Therapeutics Reports 2010 Second Quarter Financial Results 3Titan Pharmaceuticals Announces Second Quarter 2010 Financial Results 2Titan Pharmaceuticals Announces Second Quarter 2010 Financial Results 3Titan Pharmaceuticals Announces Second Quarter 2010 Financial Results 4Titan Pharmaceuticals Announces Second Quarter 2010 Financial Results 5
(Date:8/21/2014)... (PRWEB) August 21, 2014 Improv performers ... entertained residents with dementia at Silverado Turtle Creek memory ... which consists of entertainers ranging from ages 10 to ... they perform their 40-minute set. The troupe's philosophy is ... universal and allows them to touch audiences regardless of ...
(Date:8/21/2014)... 21, 2014 (HealthDay News) -- Black mothers are less ... here,s one possible reason why: Hospitals in neighborhoods with ... those in areas with more white residents, a U.S. ... are much less common in medical centers where the ... U.S. Centers for Disease Control and Prevention reported Thursday. ...
(Date:8/21/2014)... Honolulu (PRWEB) August 21, 2014 ... its 10th anniversary and a national voice in ... leaders in health disparities during the 112th National ... , Distinguished honorees included: , John Ruffin, Ph.D, ... Health and Health Disparities, whose life-long career and ...
(Date:8/21/2014)... do not routinely screen women for intimate partner ... public health researchers. Rural women who are exposed ... seek help., "Rural health care providers are uniquely ... a primary care physician and assistant professor of ... of Medicine. "However, in rural settings, it might ...
(Date:8/21/2014)... August 21, 2014 The report ... by Pollutant Control System (FGD, DeNOx, Particulate Control, ... & Steel, Chemical & Others) - Global Trends ... global industrial flue gas treatment systems & services ... market size in terms of value. The industrial ...
Breaking Medicine News(10 mins):Health News:Unicorn Clearance Improv Troupe Brings Laughter to Residents with Dementia at Silverado Memory Care 2Health News:Racial Disparities in Breast-Feeding May Start With Hospitals, Study Suggests 2Health News:W. Montague Cobb/NMA Health Institute Honors Three Outstanding Leaders in Health Disparities 2Health News:Primary care physicians can be critical resource for abused women in rural areas 2Health News:Industrial Flue Gas Treatment Systems Market Estimated to Worth $59, 546.7 Million by 2019 – Report by MarketsandMarkets 2Health News:Industrial Flue Gas Treatment Systems Market Estimated to Worth $59, 546.7 Million by 2019 – Report by MarketsandMarkets 3Health News:Industrial Flue Gas Treatment Systems Market Estimated to Worth $59, 546.7 Million by 2019 – Report by MarketsandMarkets 4
... guiding injured workers back to full-time employment should factor ... research suggests. , Workers who are injured on ... if their schedules routinely require them to work extended ... who work more than 12 hours per day or ...
... Supplementation tied to a 23% reduced risk of falling in ... Vitamin D2 supplements may help reduce the risk of falls ... of women older than 65 fall each year, and six ... In addition, fear of falling is a major problem in ...
... the lungs of patients diagnosed with idiopathic pulmonary ... of Cincinnati (UC) researchers have discovered. , According ... (pronounced new-tro-fil) cellsa type of white blood cellin ... increased risk of mortality in the first year ...
... and M&A activity in the,life sciences and healthcare sector ... more in 2008. CEOs, CFO,s and other business executives ... be,joined by some of the most sophisticated investors in ... Healthcare, April 30-May 1, 2008,in Chicago., Deal volume ...
... for ... Women, ST. ... causes nearly 2,400 deaths each day,in the United States, an average of ... 25 percent of the total U.S.,female population, there,s more reason than ever ...
... Enrollment Process, SAN JOSE, Calif., Jan. 16 ... 47 million uninsured in America are,eligible for government-sponsored ... Health Coverage Education (FHCE) has captured, on a,single ... people in need of health coverage., Combined ...
Cached Medicine News:Health News:Extended work hours should factor into return to job after injury 2Health News:Extended work hours should factor into return to job after injury 3Health News:Vitamin D May Curb Falls in High-Risk Older Women 2Health News:Rare lung disease cells indicate higher death risk 2Health News:Healthcare M&A Activity on the Rise 2Health News:Women May Enjoy Boost of Heart Health With Soy 2Health News:Internet Comes to Rescue of 14 Million Uninsured in U.S.; Providing Access to Gov. Health Programs They're Not Aware of 2Health News:Internet Comes to Rescue of 14 Million Uninsured in U.S.; Providing Access to Gov. Health Programs They're Not Aware of 3
... of fibre bronchoscopy: The HF-compatible V series ... other fibre bronchoscopes are measured., ,The ... including the FB-19TV, FB-18V and FB-15V models ... the pediatric FB-8V, offer much better image ...
... Fujinon's therapeutic fiberoptic bronchoscopes ... operating channel with a ... large channel allows for ... passage of cytology brushes. ...
... performance fiberoptic imaging from the latest ... improved its fiberscope range, focussing on ... enhanced image performance. Olympus has a ... diagnosis and therapy in the respiratory ...
Large, bright images from a bronchoscope designed for routine examination and treatment....
Medicine Products: